Trial intelligence / Profile preview

Ketorolac for Sore Throat After Thyroid Surgery

NCT02039427Completed

Sponsor
Yeungnam University College of Medicine
Start
Jan 2014
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ketorolac in postoperative sore throat (POST) (4 arms), sponsored by Yeungnam University College of Medicine. Primary endpoint: The Incidence of Postoperative Sore Throat (POST) at 24 hours. Started Jan 2014; status: completed.

02

Drugs

ketorolac
03

Conditions

postoperative sore throat (POST)

Beyond the preview

Go deeper on NCT02039427.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02039427.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call